All News

Personalising medicine will improve healthcare and create important new markets. Europe needs to move now and seize the benefits it offers, writes Richard L. Hudson.

EU telecommunications ministers have unanimously approved the new Digital Agenda, even though only four were able to make it to Granada.

A new initiative aims to develop computer and cell-based alternatives to animal toxicity testing, with the aim of replacing the use of one million animals each year in Europe.

France’s small biopharmaceutical and life science companies have been weakened by the financial crisis and had to face a drastic drop in investment in 2009.

France’s software sector has resisted the economic crisis and is innovating and creating jobs, with SMEs driving the industry, says a new report.

French innovation-focused mutual funds can make tax-efficient equity investments in ExonHit Therapeutics for renewable 3-year periods.

A week before Science|Business brings together experts from Europe to discuss personalised medicine here, we look at what’s happening in the US.